# How does LL-37 reduce oxidative stress in chronic diabetic wounds?

Canonical source: https://retacompare.com/research/how-does-ll-37-reduce-oxidative-stress-in-chronic-diabetic-wounds

Peptide Longevity Q&A · 2026-04-01


    Research indicates that LL-37, in conjunction with a nanocascade engineering workshop, effectively reduces oxidative stress in chronic diabetic wounds by eliminating reactive oxygen species (ROS), thereby enhancing the inflammatory response and facilitating wound healing.

 What the research shows

The study focused on chronic diabetic wounds, which are characterized by impaired healing due to chronic inflammation and reduced regenerative capacity. It identified the poor proliferative and differentiative ability of epidermal stem cells (EpSCs) in an inflammatory microenvironment as a significant factor in delayed wound healing. The researchers designed a nanocascade engineering workshop that includes a core-shell structure, where the core consists of an ultrasmall Cu 5.4 O nanozyme that effectively eliminates reactive oxygen species (ROS). This action transforms the pathological wound microenvironment into one that promotes regeneration. The shell of the structure is made up of plasmid DNA (pDNA) and the antibacterial peptide LL-37, which enhances gene transfection efficiency and inhibits bacterial infection. The combined effects of this nanotherapy lead to improved EpSC proliferation and differentiation, thus accelerating wound closure.

 Why it matters for longevity

This research has implications for longevity, particularly in the context of wound healing and tissue regeneration. Chronic wounds are often associated with aging and metabolic disorders like diabetes, which can hinder the body's natural healing processes. By addressing oxidative stress through the action of LL-37, the study suggests a potential pathway to enhance regenerative capabilities in older adults or those with chronic conditions. The ability to modulate the inflammatory microenvironment and promote cellular functions may contribute to improved healthspan and longevity by facilitating better wound healing and tissue repair.

 Key findings at a glance

Chronic diabetic wounds exhibit impaired healing due to chronic inflammation.

LL-37 is part of a nanocascade engineering workshop designed to enhance healing.

The core component (Cu 5.4 O) effectively eliminates reactive oxygen species (ROS).

LL-37 enhances gene transfection efficiency and inhibits bacterial infection.

The therapy promotes the proliferation and differentiation of epidermal stem cells (EpSCs).

Improved wound closure is observed in both diabetes and infection models.

 How LL-37 works (background)

LL-37 is an antimicrobial peptide that plays a role in modulating the immune response and promoting wound healing. In the context of this study, LL-37 is utilized within a nanocascade engineering framework to enhance the delivery of genetic material while simultaneously providing antibacterial properties. The incorporation of LL-37 into the nanostructure aids in reshaping the inflammatory microenvironment, which is crucial for effective tissue regeneration. The elimination of ROS by the Cu 5.4 O nanozyme further supports this process, as oxidative stress is a known barrier to healing in chronic wounds. By targeting these mechanisms, LL-37 contributes to a more favorable environment for epidermal stem cells to thrive and facilitate wound closure.

 Safety, caveats, and what we don't yet know

While the study presents promising findings regarding the use of LL-37 in chronic wound healing, it is important to note that this research is preclinical and conducted in specific models. The long-term safety and efficacy of LL-37 in humans, particularly in older populations or those with multiple comorbidities, have yet to be established. Additionally, the study does not address potential side effects or interactions with other treatments. Further research is needed to explore the full range of applications and safety profiles of LL-37 in diverse patient populations.

 Bottom line

Research indicates that LL-37 can reduce oxidative stress in chronic diabetic wounds, promoting healing by enhancing the regenerative capabilities of epidermal stem cells.

 Related questions

 Can LL-37 enhance skin regeneration in older adults?

Preliminary research suggests that LL-37 may improve skin regeneration by modulating the inflammatory response and promoting cellular functions critical for healing, particularly in aging populations.

 Does LL-37 have antibacterial properties relevant to wound healing?

Yes, LL-37 possesses antibacterial properties that can inhibit bacterial infection in wounds, which is crucial for preventing complications during the healing process.

 What role does oxidative stress play in chronic wounds?

Oxidative stress contributes to the impaired healing of chronic wounds by damaging cells and tissues, making it essential to target this factor for effective wound management strategies.

 Source: PubMed · Adv Mater · published 2026-04-01.

## Sources

- PubMed · Adv Mater: https://pubmed.ncbi.nlm.nih.gov/41834283/